Abstract
BackgroundRheumatoid arthritis (RA) is associated with significant morbidity, functional impairment, loss of quality of life, premature mortality, and substantial economic burden.1 Biological disease-modifying antirheumatic drugs (bDMARD) are key in the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
